- •This report covers 1520 deaths occurring after osteosarcoma.
- •Deaths arose after a median of about two years, but very late events occurred.
- •Most patients died without ever achieving a remission or with multiple recurrences.
- •Almost ten percent succumbed to other known causes than osteosarcoma itself.
- •Infections, secondary malignancies, and perioperative complications were frequent.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- New horizons in the treatment of osteosarcoma.N Engl J Med. 2021 Nov 25; 385: 2066-2076https://doi.org/10.1056/NEJMra2103423
- Osteosarcoma – approach to therapy.in: Arndt C.A.S. Sarcomas of bone and soft tissues in children and adolescents. Pediatr Oncol, 2021: 91-109 (10.107/978-3-030-51160-9_8)
- Osteosarcoma: the COSS experience.Cancer Treat Res. 2009; 152: 289-308https://doi.org/10.1007/978-1-4419-0284-9_15
- A European study on chemotherapy in bone-sarcoma patients aged over 40: outcome in primary high-grade osteosarcoma.Tumori. 2018 Jan-Feb; 104: 30-36https://doi.org/10.5301/tj.5000696
- Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.Eur J Cancer. 2019 Mar; 109: 36-50https://doi.org/10.1016/j.ejca.2018.11.027
- Nonparametric estimation from incomplete observations.J Am Stat Assoc. 1958; 53: 457-481
- Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.J Clin Oncol. 2002 Feb 1; 20: 776-790https://doi.org/10.1200/JCO.2002.20.3.776
- Understanding and managing methotrexate nephrotoxicity.Oncologist. 2006 Jun; 11: 694-703https://doi.org/10.1634/theoncologist.11-6-694
- Therapy-related myelodysplasia and acute myeloid leukemia.Semin Oncol. 2013 Dec; 40: 666-675https://doi.org/10.1053/j.seminoncol.2013.09.013
- Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment.Curr Treat Options Cardiovasc Med. 2014 Jun; 16: 315https://doi.org/10.1007/s11936-014-0315-4